title: Role of the renin-angiotensin system in drinking of seawater-adapted eels Anguilla japonica: a reevaluation.
abstract: The role of ANG II, a potent dipsogenic hormone, in copious drinking of seawater eels was examined. SQ-14225 (SQ), an angiotensin-converting enzyme inhibitor, infused intra-arterially at 0.01-1 microgram. kg(-1). min(-1), depressed drinking and arterial blood pressure in a dose-dependent manner. The inhibition was accompanied by a small decrease in plasma ANG II concentration, which became significant at 1 microgram. kg(-1). min(-1). After the infusate was changed back to the vehicle, the depression of drinking and arterial pressure continued for >2 h, although plasma ANG II concentration rebounded above the level before SQ infusion. By contrast, infusion of anti-ANG II serum (0.01-1 microgram. kg(-1). min(-1)) did not suppress drinking and arterial pressure, although plasma ANG II concentration decreased to undetectable levels. Plasma atrial natriuretic peptide and plasma osmolality, which influence drinking rate in eels, did not change during SQ or antiserum infusions. These results suggest that the renin-angiotensin system plays only a minor role in the vigorous drinking observed in seawater eels. The results also suggest that the antidipsogenic and vasodepressor effects of SQ in seawater eels are not due solely to the inhibition of ANG II formation in plasma.
authors.affiliation: Ocean Research Institute, The University of Tokyo, Tokyo 164-8639, Japan. takei@ori.u-tokyo.ac.jp
authors.forename: Y
authors.initials: Y
authors.lastname: Takei
authors.forename: T
authors.initials: T
authors.lastname: Tsuchida
mesh_terms: D000222:Adaptation, Physiological / Q000502:physiology*; D000804:Angiotensin II / Q000097:blood / Q000276:immunology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000811:Anguilla / Q000502:physiology*; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D009320:Atrial Natriuretic Factor / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002216:Captopril / Q000494:pharmacology; D004326:Drinking / Q000187:drug effects / Q000502:physiology*; D009500:Neutralization Tests; D009994:Osmolar Concentration; D012084:Renin-Angiotensin System / Q000502:physiology*; D012623:Seawater; D012964:Sodium / Q000097:blood; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000906:Antibodies; D000804:Angiotensin II; D009320:Atrial Natriuretic Factor; D002216:Captopril; D012964:Sodium